Chronic Kidney Disease

FLOW: Kidney, Cardiovascular, Mortality, Metabolic and Safety Results

Richard Pratley

Watch time: 6m 39s
ESC 24: FINE-HEART: Finerenone in HF & CKD

Muthiah Vaduganathan

Watch time: 4m 24s
ADA 24: FLOW Trial: Kidney Outcomes in Patients Treated with Semaglutide

Vlado Perkovic

Watch time: 5m 40s
Importance of Testing for CKD Among Patients With Type 2 Diabetes

Pam Taub, Nikolaus Marx

Watch time: 10m 51s

Anjay Rastogi

Timing of Cardio-Kidney Protection with SGLT2 Inhibitors

Radcliffe Cardiology, Ola Wisniewska ; Special Editor: Greg Guillory

HFA 24: FINE-HEART: Design & Baseline Characteristics

Muthiah Vaduganathan

Watch time: 4m 40s
HFA 24: Timing of Cardio-Kidney Protection with SGLT2i

Muthiah Vaduganathan

Watch time: 5m 24s

Andrew Frankel, Shelley Zieroth et al

IMPACT CKD: 10-year Outlook on CKD

Jerome Rossert

Watch time: 5m 22s
Optimisation of Guideline-directed Medical Therapy in Cardiorenal Patients

Ileana L Piña, David Wheeler, , et al

Watch time: 45m 39s
SGLT2i: Best Practices in Implementation Across HF, Diabetes and CKD

Clara Saldarriaga, Shelley Zieroth, , et al

Watch time: 37m 3s

David Wheeler, Carol Pollock et al

Muthiah Vaduganathan

Effects of Dapagliflozin in Patients With Chronic Kidney Disease, With and Without Heart Failure

John JV McMurray

Watch time: 6m 48s

Andrew Frankel, Shelley Zieroth, , et al

Watch time: 1h 7m 6s

Andrew Frankel, Shelley Zieroth et al

Importance of Testing for CKD Among Patients With Type 2 Diabetes

Pam Taub, Nikolaus Marx

Watch time: 10m 51s

Anjay Rastogi

ESC 22: FIDELITY: Finerone in Pts With Chronic Kidney Disease

Gerasimos Filippatos

Watch time: 5m 44s
ERA 23: REVEAL-CKD: Underdiagnosis of CKD

Navdeep Tangri

Watch time: 3m 32s
HFA 24: FINE-HEART: Design & Baseline Characteristics

Muthiah Vaduganathan

Watch time: 4m 40s
Radcliffe & CardioNerds @AHA22: EMPA-Kidney: Empagliflozin & CV Outcomes in Patients with Chronic Kidney Disease

Kate Wilcox, David Preiss

Watch time: 18m 1s
ESC 24: FINE-HEART: Finerenone in HF & CKD

Muthiah Vaduganathan

Watch time: 4m 24s

Media

Ileana L Piña, Gianluigi Savarese, , et al

Ileana L Piña, Gianluigi Savarese, , et al

Stefan Anker, Javed Butler, Shelley Zieroth, et al

Stefan Anker, Javed Butler, Shelley Zieroth, et al

Vijay Chopra, Deepak L Bhatt, George L Bakris, et al

ESC 22: FIDELITY: Finerone in Pts With Chronic Kidney Disease

Gerasimos Filippatos

Watch time: 5m 44s

James Burton, David Wheeler, Carol Pollock, et al

James Burton, David Wheeler, Carol Pollock, et al

FLOW: Kidney, Cardiovascular, Mortality, Metabolic and Safety Results

Richard Pratley

Watch time: 6m 39s
Importance of Testing for CKD Among Patients With Type 2 Diabetes

Pam Taub, Nikolaus Marx

Watch time: 10m 51s

Anjay Rastogi

Radcliffe & CardioNerds @AHA22: EMPA-Kidney: Empagliflozin & CV Outcomes in Patients with Chronic Kidney Disease

Kate Wilcox, David Preiss

Watch time: 18m 1s

Articles